Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

G. Gebhart, L. E. Lamberts, Z. Wimana, C. Garcia, P. Emonts, L. Ameye, S. Stroobants, M. Huizing, P. Aftimos, J. Tol, W. J. G. Oyen, D. J. Vugts, O. S. Hoekstra, C. P. Schroder, C. W. Menke-van der Houven van Oordt, T. Guiot, A. H. Brouwers, A. Awada, E. G. E. de Vries, P. Flamen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)619-624
JournalAnnals of Oncology
Volume27
Issue number4
DOIs
Publication statusPublished - Apr 2016

Cite this